The Veros COVID-19 test yields accurate and rapid results and is easy to use in patients with high and moderate viral loads in the ED setting.

Public concerns about contracting RSV (respiratory syncytial virus) have significantly declined during the past year.

The FDA granted Priority Review to gepotidacin for the treatment of female adults and adolescents with uncomplicated UTI.

The risk for an incident diagnosis of type 2 diabetes is increased in the 6 months following SARS-CoV-2 infection.

The Food and Drug Administration (FDA) has granted Fast Track designation to Shigella4V for the prevention of shigellosis.

Member countries of the UN endorsed a broad set of commitments to address the global burden of AMR at the UNGA 2024 high-level meeting.